Aethlon Medical expands ATM offering by $542K, increasing potential dilution
AEMD sits 51% above its 52-week low of $1.36.
Summary
Aethlon Medical has expanded its At-The-Market (ATM) offering capacity by an additional $542,716, as disclosed in recent SEC filings. This move provides much-needed liquidity for the micro-cap company, which issued a going concern warning in its last 10-Q due to insufficient cash. However, the offering represents a substantial potential dilution, equivalent to over 16% of its current market capitalization, adding to the $1.85 million already sold under the prior prospectus. This highlights the company's ongoing financial challenges and its reliance on equity financing.
At the time of this announcement, AEMD was trading at $2.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.36 to $29.88. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.